Lancashire and South Cumbria
Formulary
Formulary
6 Endocrine system
06-01-01-03 Hypodermic equipment
| Insulin pumps |
|
Formulary
|
For supply via secondary care only with Blueteq approval. Classified as |
|
|
Red in secondary care and
in Primary Care| Prescribable CGM |
|
Formulary
|
e.g. FreeStyle Libre, Dexcom Only for patients with a diagnosis of diabetes. For patients who do not routinely attend appointments with specialist clinicians prescribable CGM may be supplied in primary care by a clinician responsible for the wider care and management of the patient’s diabetes.
For recommendations on the supply of CGM please consult the following NICE guidelines:
NICE NG28: Type 2 diabetes in adults: management Section 1.7.1 - 1.7.10
NICE NG17: Type 1 diabetes in adults: diagnosis and management Section 1.6.10 - 1.6.18
NICE NG 18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management Section 1.2.60 - 1.2.70
NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period Section 1.3.17-1.3.20 |
|
Links
Biosimilars policy statement- Diabetes UK: Diabetes when you’re unwell
- LSCMMG: Diabetes - Choice of Safety Pen Needles and Lancets
- LSCMMG: Diabetes - Pen Needles/Lancets
- LSCMMG: Diabetes - Position Statement Safety Needles and Safety Lancets
- LSCMMG: Diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes
- LSCMMG: Diabetes: Recommended meters, strips and devices
LSCMMG: GLP-1 patient contract- LSCMMG: Osteoporosis: Secondary fracture prevention patient treatment pathway
- LSCMMG: Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
- LSCMMG: Trans Female Gender Dysphoria Information Sheet
- LSCMMG: Trans Male Gender Dysphoria Information Sheet
- MHRA: Diabetes and driving
- MHRA: Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme
- MHRA: Recall of certain batches of Autopen, Dec 14
- NHSE guidance to primary care about unregulated providers who supply hormone medications to children and young people for gender incongruence
- NICE NG17: Type 1 diabetes in adults: diagnosis and management
- NICE NG18: Diabetes (type 1 and type 2) in children and young people: diagnosis and management
- NICE NG19: Diabetic foot problems: prevention and management
- NICE NG28: Type 2 diabetes in adults: management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period